Drug intelligence / Profile preview

Prevebe Preterm

Development stage: Unknown
Lead developer: LYS PHARMA
Administration: Oral

Overview

Prevebe Preterm is a dietary supplement developed by LYS PHARMA, a South Korean company specializing in women's health. It is specifically formulated as a nutritional intervention to aid in the prevention of preterm birth. The product is part of the Prevebe brand line, which focuses on maternal and fetal health. Prevebe Preterm typically contains a combination of specialized probiotics, such as *Lactobacillus rhamnosus* HN001 and *Lactobacillus acidophilus* La-14, which are intended to support a healthy vaginal microbiome. By maintaining microbial balance and providing essential micronutrients, the supplement aims to reduce risk factors associated with premature delivery and support overall pregnancy maintenance.

Brand names: Prevebe Preterm프리베베 프리텀
Other names: Prevebe Preterm

Beyond the preview

Go deeper on Prevebe Preterm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prevebe Preterm.

Explore the full profile